Telehealth startups that offer Americans quick and easy access to mental health drugs have been on the rise in recent years, but now at least one may soon face legal trouble over allegations it pressured nurses into prescribing drugs.Cerebral, an emerging telehealth startup that has suffered from its share of controversy in recent months, was subpoenaed by the U.S. Department of Justice (DoJ) on May 4, reports, over allegations the company was misusing prescription drugs like Xanax and Adderall.The San Francisco-based company has been under fire in recent months over potentially misleading and harmful ads on social media platforms like TikTok - which is primarily used by children and teenagers - and over a report from the (WSJ) alleging it was pressuring nurses to prescribe medication for conditions like .
Load More
Load More